TVA Medical: TVA Medical touts meta-analysis of everlinQ endoAVF treatments

TVA Medical today released data from a meta-analysis study of its everlinQ endovascular arteriovenous fistula system designed for hemodialysis access, touting a high procedure success rate and a high rate of fistula maturation. Results from the 236-patient trial were presented at the Leipzig Interventional Course 2018, the Austin, Texas-based company said. Data in the meta-analysis [...]The post TVA Medical touts meta-analysis of everlinQ endoAVF treatments appeared first on MassDevice.